NIH develops improved mouse model of alcoholic liver disease

March 1, 2013, National Institutes of Health
A mouse drinks from a liquid diet containing 5 percent alcohol. Scientists at NIAAA have developed a feeding pattern that allows them to better study liver damage caused by heavy drinking.

(Medical Xpress)—Scientists may be better able to study how heavy drinking damages the liver using a new mouse model of alcohol drinking and disease developed by researchers from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health. The model incorporates chronic and binge drinking patterns to more closely approximate alcoholic liver disease in humans than any existing method. A report of the new model appears in the March issue of the journal Nature Protocols.

"The NIAAA model represents a significant advance in understanding the progression of alcoholic liver disease, which in severe cases can lead to liver failure and death. By replicating both chronic and , we are able to simulate the natural drinking patterns of many alcoholic hepatitis patients and the resulting ," said Kenneth R. Warren, Ph.D., acting director of the NIAAA.

In the body, the liver filters out harmful substances and plays a key role in breaking down alcohol. Alcoholic liver disease (ALD) refers to a broad range of liver injury caused by drinking. Some forms are mild and reversible while others, such as cirrhosis, are life-threatening and irreversible. , an early form of ALD marked by a build-up of fat in liver cells, occurs in almost all heavy drinkers, but can usually be reversed if the individual stops drinking.

About 20–40 percent of heavy drinkers will develop more severe forms of alcoholic liver disease, including alcoholic hepatitis, which involves inflammation and swelling of the liver, and cirrhosis, which can lead to as accumulates on the organ. Scientists do not completely understand why some people progress to more severe forms of ALD, although gender, obesity, genetic and dietary factors, and smoking may play a role.

"Many of the models for currently used do not evoke the full range of symptoms or are expensive and technically difficult," said senior author Bin Gao, M.D., Ph.D., chief of the NIAAA Laboratory of Liver Diseases.

In the most common model currently used, mice are allowed to feed for four to six weeks on a liquid diet that contains 5 percent ethanol. But without the additional liver injury commonly seen from binge alcohol exposure, this model only induces mild fat accumulation in , slightly elevated liver enzymes indicating damage, and little or no inflammation. Models that are better at replicating more severe forms of ALD involve infusing alcohol directly into the mouse's stomach, which requires intensive medical care for the animals, a high degree of technical expertise, and costly equipment.

The NIAAA model involves a 10-day feeding of an alcohol-containing liquid diet, followed by a single high-dose feeding of alcohol to approximate binge drinking. This results in marked elevation of fatty liver and enzymes indicating liver injury.

"The NIAAA model is less costly, more time efficient, and easy to perform. Importantly, it may more closely resemble the progression of human alcoholic hepatitis," said Dr. Gao. He noted that it may also be useful in studying damage to other organs caused by heavy drinking, including the heart, lungs, kidneys, pancreas, and central nervous system.

Explore further: Binge drinking can dramatically amplify damage to the liver

More information: Bertola, A. et al. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nature Protocols. February 28, 2013.

Related Stories

Binge drinking can dramatically amplify damage to the liver

January 22, 2013
Alcoholic liver disease (ALD) is characterized by a fatty liver, hepatitis, fibrosis, and cirrhosis. Binge drinking is on the rise worldwide, and is particularly common in the U.S. A review of studies addressing the effects ...

Modest alcohol intake associated with less inflammation in patients with common liver disease

May 15, 2012
NAFLD (non-alcoholic fatty liver disease) is the most common type of liver disease in the developed world, affecting up to one-third of the US population. NAFLD is often associated with obesity and other parameters of the ...

New clinical practice guidelines on alcoholic liver disease published

April 19, 2012
EASL today announced the publication of a new clinical practice guideline (CPG) in the area of Alcoholic Liver Disease (ALD), bringing the number of CPGs published to date to eight.

Recommended for you

Researchers illustrate how muscle growth inhibitor is activated, could aid in treating ALS

January 19, 2018
Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for ...

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

Secrets of longevity protein revealed in new study

January 17, 2018
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure ...

The HLF gene protects blood stem cells by maintaining them in a resting state

January 17, 2018
The HLF gene is necessary for maintaining blood stem cells in a resting state, which is crucial for ensuring normal blood production. This has been shown by a new research study from Lund University in Sweden published in ...

Magnetically applied MicroRNAs could one day help relieve constipation

January 17, 2018
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.